Condition
Dissecting Aneurysm of Cerebral Artery
Total Trials
5
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Unknown3
Recruiting2
Clinical Trials (5)
Showing 5 of 5 trials
NCT06541106RecruitingPrimary
Registry of Endovascular Treatment for Vertebrobasilar Dissecting Aneurysms in China
NCT06405971Not ApplicableRecruitingPrimary
Metformin in Patients with Unruptured Vertebrobasilar Dissecting Aneurysms (METTLE)
NCT04943783Not ApplicableUnknownPrimary
Atorvastatin in the TREATment of Intracranial Unruptured VertebroBasilar Dissecting Aneurysms
NCT03940859UnknownPrimary
Dynamic Contrast-Enhanced Magnetic Resonance Imaging Analysis for Prognosis of Intracranial Dissecting Aneurysm With Intramural Hematoma After Endovascular Treatment
NCT02914288Unknown
Prospective Observation for Serial Changes of Acute Intracranial Artery Dissection Using High Resolution MRI
Showing all 5 trials